Methylene Blue

Methylene blue has a range of medicinal properties, and its use in intravenous (IV) therapy has gained attention for various potential health benefits. One of its primary medical applications is the treatment of methemoglobinemia, a condition in which hemoglobin is unable to release oxygen effectively to the body's tissues. By converting methemoglobin back into hemoglobin, methylene blue improves oxygen delivery.

Beyond this, research suggests methylene blue may enhance cognitive function and offer neuroprotective effects due to its ability to improve mitochondrial function in the brain, which has implications for treating neurodegenerative diseases like Alzheimer's and Parkinson's. Additionally, methylene blue acts as a potent antioxidant, reducing oxidative stress by neutralizing free radicals, thereby protecting cells from damage and aging, a benefit being explored in anti-aging and longevity medicine.

​

Methylene blue also has notable antimicrobial properties, making it useful in fighting certain bacterial and fungal infections, and it has been used in some cases to treat urinary tract infections or as a supportive treatment for sepsis. Moreover, there is early evidence to suggest that low doses of methylene blue may have mood-stabilizing and antidepressant effects, possibly due to its influence on brain energy metabolism and neurotransmitters. In emergency medicine, methylene blue IV has been utilised to help manage shock and low blood pressure in conditions such as septic shock or vasoplegic syndrome after cardiac surgery, by reducing nitric oxide levels and improving cardiovascular function.

​

Another promising aspect of methylene blue IV is its potential to support cellular metabolism by boosting mitochondrial energy production, which is essential for overall health and physical performance. This has made it of interest in anti-aging circles, as enhanced cellular energy production could delay age-related decline in cellular function.